000			03137nam a22003735i 4500
001			82316
003			ES-MaUEC
005			20230207040406.0
007			cr nn 008mamaa
008			150309s2015 gw | s |||| 0|eng d
020			_a9783319152936
024	7		_a10.1007/978-3-319-15293-6 _2doi
050		4	_aRC683.5.E5 _b2015 EB
082	0	4	_a616.12
100	1		_aRautaharju, Pentti M. _995163 _0Local
245	1	4	_aThe Female Electrocardiogram : _bSpecial Repolarization Features, Gender Differences, and the Risk of Adverse Cardiac Events _cby Pentti M. Rautaharju
260			_aCham, Switzerland _bSpringer _c2015
300			_a1 recurso en línea (XIV, 141 p.) _b35 ilustraciones, 24 ilustraciones en color
336			_aTexto (visual) _btxt _2rdacontent
337			_aelectrónico _bc _2rdamedia
338			_arecurso electrónico _bcr _2rdacarrier
505	0		_aSpecial Features of the female electrocardiogram -- Gender Differences Emerging During Adolescence in Heart Rate, QRS Duration and ST Elevation -- The Repolarization Model - Conceptual Considerations -- Electrocardiographic Predictors Coronary Heart Disease Death in Women -- ECG Predictors of Atrial Fibrillation and Heart Failure -- ECG Predictors of Sudden Cardiac Death -- The Utility of the Electrocardiogram in Left Ventricular Hypertrophy -- Ventricular Conduction Defects in Women -- ST-T waveform features, QT and mortality risk -- Statistical expressions for peaked vs. flat T wave and T wave asymmetry
520	3		_aRecent research cited above has documented that QRS/T angle and other novel repolarization measures of deviant repolarization are potent predictors of cardiac morbidity and mortality over and above the traditional risk factors such as old ECG-MI, ECG-LVH or QT prolongation. A novel ECG model of repolarization based on electrophysiological considerations developed by the author has been the cornerstone in this search for improved predictors. The concepts involved in these quantitative methods are advanced and clinicians may not readily understand their utility in patient care. Their value is perhaps more easily comprehended by investigators who are collaborating in preventive studies and evaluation of adverse effects of cardio-active agents. It is expected that this book will facilitate understanding how these new ECG finding can be used in both clinical and epidemiological application
710	2		_aSpringerLink (Online service) _0Local _9106996
942			_2lcc _cLE
650		7	_aElectrocardiografía _9140377 _0comprobar BNE19900984382 _2embne
650		7	_9138557 _aCardiología _0comprobar BNE19900961332 _2embne
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://link.springer.com/book/10.1007/978-3-319-15293-6 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
901			_ai9783319152936
907			_a.b12909567 _b10-10-17 _c10-02-16
988			_aSpringer_Medicine_2015
998			_am _a_alco _a_vill _b17-08-17 _cm _dz _ek _feng _ggw _h4
945			_aRC683.5 .E5 R388 2015 EB _g1 _ieBOOK _j0 _lmae _o- _pEUR0.00 _q- _r- _sb _t15 _u0 _v0 _w0 _x0 _y.i11577241 _z06-04-17
999			_c82316 _d82316 _x1